TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 21 filers reported holding TRINITY BIOTECH PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $2,379,000 | -7.1% | 131,719 | -1.0% | 0.14% | -7.4% |
| Q1 2015 | $2,560,000 | +20.4% | 132,995 | +9.5% | 0.15% | +14.7% |
| Q4 2014 | $2,126,000 | -4.4% | 121,416 | -0.3% | 0.13% | -16.8% |
| Q3 2014 | $2,225,000 | -21.9% | 121,788 | -1.5% | 0.16% | -19.3% |
| Q2 2014 | $2,848,000 | -5.8% | 123,654 | -0.9% | 0.19% | -13.5% |
| Q1 2014 | $3,024,000 | +141.1% | 124,820 | +150.3% | 0.22% | +146.7% |
| Q4 2013 | $1,254,000 | – | 49,870 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prospect Capital Advisors, LLC | 336,550 | $3,924,000 | 4.65% |
| ACK Asset Management | 979,600 | $11,422,000 | 4.49% |
| Balter Liquid Alternatives, LLC | 161,284 | $1,881,000 | 4.33% |
| GOLDMAN CAPITAL MANAGEMENT INC | 396,690 | $4,625,000 | 3.50% |
| Paradice Investment Management LLC | 1,435,724 | $16,741,000 | 2.23% |
| Adirondack Research & Management Inc. | 415,353 | $4,843,000 | 1.76% |
| Lapides Asset Management, LLC | 705,100 | $8,221,000 | 1.47% |
| Park West Asset Management LLC | 900,000 | $10,494,000 | 0.99% |
| Benchmark Capital Advisors | 83,541 | $974,000 | 0.86% |
| HEARTLAND ADVISORS INC | 1,290,010 | $15,042,000 | 0.79% |